Shingo Suzuki Ph.D.

Postdoctoral fellow, UC, San Francisco

Dr. Suzuki received his Ph.D. from the University of Kumamoto, JAPAN, in 2014. His doctoral studies included the elucidation of ATP-binding cassette (ABC) transporter protein quality control associated with hereditary atherosclerosis and CF as well as the development of gene therapy by SFHR-mediated sequence-specific modification. He had studied CF pluripotent stem cell biology and regenerative medicine as well as gene therapy with Dr. Dieter Gruenert in the Department of Otolaryngology-Head and Neck Surgery and with Dr. Yuet. W. Kan in the Department of Medicine - Genomic medicine in the University of California, San Francisco, USA, from 2012 to 2016. At present he has been studying lung development and extending his gene-editing knowledge to apply them CF therapy with Dr. Brian Davis at Institute of Molecular Medicine in the University of Texas Health Science Center at Houston. His current research interests include establishment of gene and cell therapies using induced pluripotent stem cells to repair and regenerate organs damaged by CF-associated pathology.